Comprehensive pan-cancer analysis of MEX3A in human tumors
A systematic pan-cancer characterization of MEX3A is provided and supports its potential role as a prognostic biomarker and a hypothesis-generating candidate for future mechanistic and clinical validation, as well as suggesting that MEX3A may participate in RNA regulatory networks and tumor-immune microenvironment interactions.